Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Total Non-Current Liabilities (2023 - 2024)

Historic Total Non-Current Liabilities for Mangoceuticals (MGRX) over the last 2 years, with Q3 2024 value amounting to $12167.0.

  • Mangoceuticals' Total Non-Current Liabilities fell 8507.26% to $12167.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $12167.0, marking a year-over-year decrease of 8507.26%. This contributed to the annual value of $64961.0 for FY2023, which is N/A changed from last year.
  • Mangoceuticals' Total Non-Current Liabilities amounted to $12167.0 in Q3 2024, which was down 8507.26% from $30117.0 recorded in Q2 2024.
  • In the past 5 years, Mangoceuticals' Total Non-Current Liabilities ranged from a high of $97391.0 in Q2 2023 and a low of $12167.0 during Q3 2024